CClinicalTrials.gg
Sign In
Status unknownNCT03900169Updated Jun 7, 2021

Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent Ppci

An observational study in Familial Hypercholesterolemia, sponsored by Assiut University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2021-06-07.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
2
Sex
All
01

Study summary

Famulial hypercolerstremia as risk factor

Read the detailed description

Familial hypercolerestremia ad risk factor in stemi patient who underwent Ppci

02

Conditions studied

  • Familial Hypercholesterolemia
03

In context

Hyperlipoproteinemia Type II

245 studies on the registry are indexed under Hyperlipoproteinemia Type II; 52 are open to participants now.

This study's enrollment of 2 is below the median of 743 across 66 observational studies indexed under Hyperlipoproteinemia Type II.

Browse Hyperlipoproteinemia Type II studies →

Lead sponsor

Assiut University is the lead sponsor of 4,916 studies on the registry; 2,113 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Probability sample

Study population

Stemi patient

Inclusion criteria

-all patient that underwent Ppci

Exclusion criteria

Exclusion Criteria:

  • Previous ischemic patient
  • Patient with raised renal chemistry
  • Patient for CABG
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
2 participants (actual)
Patient registry
No

Groups and cohorts

  • Stemi patient

    Stemi patient who underwent Ppci

    Genetic: Genetic

Interventions

  • GeneticGenetic

    Lipid profile

06

What researchers measure

Primary outcomes

  1. Correlation between familial hypercolerstremia and prognosis of patients in PPCI

    Correlation between familial hypercolerstremia and prognosis of patients in PPCI

    Time frame: One year

  2. Correlation between non familial hypercolerstremia and prognosis of patients in PPCI

    Correlation between non familial hypercolerstremia and prognosis of patients in PPCI

    Time frame: One year

07

Study locations

1 site
  • Amira harby
    Assiut, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03900169
Lead sponsor
Assiut University
Responsible party
Amira Harby (Principle investigator, Assiut University) — Principal investigator
First posted
Apr 2, 2019
Start date
Nov 1, 2020
Primary completion
Aug 1, 2021 (estimated)
Completion
Nov 1, 2021 (estimated)
Last update
Jun 7, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hyperlipoproteinemia Type II→

Other studies from this sponsor

Assiut University

Start the discussion